Japan-Weekly Strategy Report With the “politics-driven market” settling down, time to close in on cheap stocks June 18, 2019 715

Report type: Weekly Strategy

 

With the “politics-driven market” settling down, time to close in on cheap stocks

As a result of rising expectations of US interest rate cuts arising from US employment statistics announced on 7/6, and through the favorable response to announcement of an indefinite freeze on Mexican tariffs, the Nikkei average started above 21,000 points on 10/6, and rose to 21,259 points on 12/6.  However, as the calculation dates for the Special Quotations (Major SQ) for Index Futures Trading and Index Option Trading are expected to overlap on 14/6, there are concerns about the direction of market movements after that due date.  As a result, until 13/6, trades had been relatively thin. As stated in the 1/4 Weekly Report, a Nikkei average of 21,000 points is an important milestone for the market in the medium to long term.  In terms of fundamentals, the weighted average PBR (Price Book-Value Ratio) of the Nikkei average is a value that is readily noticed when the liquidation value falls below 1.0 times.  It may therefore be said that it is a suitable level for one to return to the starting point in preparation for the next market phase.  

It was widely expected that the Abe administration would delay the consumption tax hike and dissolve the House of Representatives in preparation for the House of Councilors election scheduled for 21/7.  However, it now appears that the consumption tax hike will be implemented as scheduled in October, and it is increasingly apparent that a snap election dissolving the House of Representatives will not be held.  There are few expectations that a bull stock market can be recreated in a way similar to that in Autumn 2017 through a surprise snap election.  There are also concerns that a tax hike will adversely affect the economy. In response to last-minute surge in demands before the tax hike, the government has already prepared budgets for projects like “National Resilience”, “Cashless Settlement” and “Free Childcare”. We can expect domestic demand to support the Japanese economy, including labor-saving investments in response to labor shortages.

However, if the FSA’s estimate that “a person needs 20 million yen after retirement” is used politically from the perspective of the pension system and becomes an issue during the House of Councilors election, then there is concern that election results will not be favorable for the ruling party.  Regarding this point, let’s separate it from the pension system, and hope for discussions on the rationality of considering the usage of “Tsumitate NISA” and “iDeCo” from their early stages for asset formation.  In addition, with regards cheap stocks, shareholders may begin to demand at shareholder meetings that companies strengthen shareholder returns through share buybacks.  The market environment is expected to be subject to the future of “politics-driven market” situations and the uncertainty of the Japanese economy after the consumption tax hike. Nevertheless, this is the time to look at stocks perceived as cheap in terms of fundamentals. It is indeed a good strategy to hold on to long-lasting investment focus that will not be influenced by external factors.   

In the 17/6 issue, we will be covering Kobe Bussan (3038), Toray (3402), Mercari (4385), Hitachi Metals (5486), Ya-Man (6630) and Autobacs Seven (9832).

 

  • Mercari, Inc (4385)   3,060 yen (14/6 closing price)

・Established in 2013. Operates the “Mercari” market place for person-to-person (C2C) transactions based on smartphones.  Also operating Mercari JP (Japan), Mercari US (US) and “Merpay” for cashless settlements. 

・For 3Q (2018/7-2019/3) results of FY2019/6 announced on 9/5, net sales increased by 43.0% to 37.378 billion yen compared to the same period the previous year. Operating income worsened from negative 1.896 billion yen for the same period the previous year to negative 5.981 billion yen.  SG&A expenses increased by 46.3% due to increase in upfront investments for growth.  Total domestic Gross Merchandise Value (GMV) of Mercari US had increased by 53.5% to 261 million USD.

・For FY2019/6 plan, net sales is expected to increase by 39.8-45.4% to 50.0-52.0 billion yen compared to the previous year.  Announced on 13/6 to take the “Mercari” business out of business consolidation.  Total domestic GMV for Mercari US had increased by 70% to 103 million USD for the 2019/1-3 period compared to the same period the previous year. In the US, where “garage sale” practices have taken root, the potential for a “smartphone version garage sale” is expected to be huge.  We can therefore look forward to accelerated growth in US domestic GMV

  • Toray Industries, Inc (3402)   8 yen (14/6 closing price)

・Basic material manufacturer established by Mitsui & Co., Ltd, in 1926.  Conducts businesses related to fiber, functional chemical products, carbon fiber composite materials, environment / engineering, life sciences, etc.  Has top global share for carbon fiber and polyester film for aircrafts.  Only company in the world in the water treatment business possessing all four types of separation membranes.

・For FY2019/3 results announced on 14/5, net sales increased by 8.3% to 2.3888 trillion yen compared to the same period the previous year, operating income decreased by 9.6% to 141.469 billion yen, and current income decreased by 17.2% to 79.373 billion yen.  Was not able to transfer fuel price increases to product prices. Costs related to launch of new projects at the overseas composite subsidiary and acquisition-related expenses had also impacted performance negatively.

・For FY2020/3 plan, net sales is expected to increase by 5.9% to 2.53 trillion yen compared to the previous year, operating income to increase by 13.1% to 160.0 billion yen, and current income to increase by 17.2% to 93.0 billion yen.  According to media reports, company may apply for approval of production and sales from the Ministry of Health, Labor and Welfare within 2019 for a test kit that can detect various types of cancers simply from one drop of blood.

 

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!